{"id":18697,"date":"2021-11-09T05:01:00","date_gmt":"2021-11-09T05:01:00","guid":{"rendered":"https:\/\/eodishasamachar.com\/en\/2021\/11\/09\/microban-international-announces-a-new-range-of-antiviral-technologies\/"},"modified":"2021-11-09T05:01:00","modified_gmt":"2021-11-09T05:01:00","slug":"microban-international-announces-a-new-range-of-antiviral-technologies","status":"publish","type":"post","link":"https:\/\/eodishasamachar.com\/en\/2021\/11\/09\/microban-international-announces-a-new-range-of-antiviral-technologies\/","title":{"rendered":"Microban\u00ae International announces a new range of antiviral technologies"},"content":{"rendered":"<p> \n<\/p>\n<div>\n<p>NORTH CAROLINA, USA&#13;<br \/>\n&#8211; News Direct &#8211; 9 November 2021 &#8211;\u00a0<a href=\"http:\/\/www.microban.com\/\">Microban International<\/a>, the global leader in&#13;<br \/>\nantimicrobial solutions, odour control and residual sanitisation\/disinfection&#13;<br \/>\nsolutions, is pleased to announce a new range of antiviral technologies that are&#13;<br \/>\nproven to reduce viral loading on products and surfaces. Microban has long been&#13;<br \/>\na trusted partner in a wide range of sectors \u2013 from consumer and healthcare to&#13;<br \/>\nindustrial and construction \u2013 and this announcement adds to the versatility of&#13;<br \/>\nthe company&#8217;s technology portfolio.<\/p>\n<p style=\"text-align: center\"><img src=\"https:\/\/images.media-outreach.com\/Thumb\/500x0\/195596\/Microban.jpg#image-195596\" width=\"500\"\/><\/p>\n<p>\u00a0<\/p>\n<p>Microban<sup>\u00ae<\/sup> technology can be incorporated into various materials during&#13;<br \/>\nmanufacturing, becoming part of the product&#8217;s structure to provide inherent and&#13;<br \/>\nenduring protection from microbes. Recent data demonstrates that new antiviral technologies&#13;<br \/>\nfrom Microban conform to both ISO 18184 \u2013 which assesses the antiviral performance&#13;<br \/>\nof treated textile products, such as woven and knitted fabrics, fibres, yarns,&#13;<br \/>\nand braids \u2013 and ISO 21702, which measures activity in treated plastics and&#13;<br \/>\nother non-porous surfaces. Thorough testing was performed to evaluate the&#13;<br \/>\nefficacy of each product type against many viruses, including bacteriophage&#13;<br \/>\nPhi6, an important surrogate virus for SARS-CoV-2. The results showed that articles&#13;<br \/>\ntreated with these technologies can now benefit from reduced viral loading* by up&#13;<br \/>\nto 99 %.<\/p>\n<p>\u00a0<\/p>\n<p>Antiviral technologies from Microban inhibit the viruses&#8217; ability to&#13;<br \/>\nremain viable on surfaces. The modes of action vary, disrupting the structure&#13;<br \/>\nof either the outer protein coat \u2013 to prevent viruses from recognising or&#13;<br \/>\nbinding to host cells \u2013 or nucleic acid payload, to prevent viral replication.&#13;<br \/>\nThis gives manufacturers a valuable product feature and provides consumers with&#13;<br \/>\nadded peace of mind. <\/p>\n<p>\u00a0<\/p>\n<p>Michael Ruby, President of Microban International, explained: &#8220;We are&#13;<br \/>\nexcited with the latest results confirming the antiviral activity of our new technologies.&#13;<br \/>\nAssessing antiviral efficacy in treated products to a standard that meets the&#13;<br \/>\ncomplex regulatory landscape is an arduous process, but we have been confident&#13;<br \/>\nthroughout that our innovative solutions conformed to the rigorous ISO&#13;<br \/>\nstandards. Our world-class research team and global in-house regulatory&#13;<br \/>\ndepartment worked diligently to ensure that the technology is recognised as effective&#13;<br \/>\nand compliant across various markets, to support partners with their claims and&#13;<br \/>\ngive customers even greater confidence in products protected with Microban antiviral&#13;<br \/>\ntechnology.&#8221;<\/p>\n<p>\u00a0<\/p>\n<p>Following the start of the COVID-19 pandemic, there was a monumental&#13;<br \/>\nupsurge in demand for antiviral technology in products and it is readily acknowledged&#13;<br \/>\nthat Microban was not the first in the industry to make antiviral claims.&#13;<br \/>\nInstead, the company invested a considerable amount of time and resources to ensure&#13;<br \/>\nthat its antiviral technologies were not only scientifically proven to be&#13;<br \/>\neffective in reducing viral loading on surfaces and products, but that they&#13;<br \/>\ncould also be used in a regulatory compliant manner by brands and manufacturers&#13;<br \/>\nacross a variety of territories and product types. Microban is committed to being&#13;<br \/>\na reliable and trusted industry leader, and its unrivalled regulatory expertise&#13;<br \/>\ncan help to ensure that partners are aware of the implications that antiviral&#13;<br \/>\nclaims can have on their product types in the countries where they are being&#13;<br \/>\nsold. <\/p>\n<p>\u00a0<\/p>\n<p>For more information on Microban&#8217;s new range of antiviral technologies&#13;<br \/>\nand registration requirements in your territory, visit <a href=\"https:\/\/www.microban.com\/antiviral\/technologies\">https:\/\/www.microban.com\/antiviral\/technologies<\/a> or contact your Microban&#13;<br \/>\nrepresentative. <\/p>\n<p><em>\u00a0<\/em><\/p>\n<p><em>*Antiviral efficacy may vary&#13;<br \/>\ndepending on substrate type, application dosage of the treatment, impurities,&#13;<br \/>\nand application procedure. <\/em><em>Only&#13;<br \/>\nMicroban antiviral technologies that are registered with US EPA and are EU BPR&#13;<br \/>\ncompliant are being offered for sale. In the US, antiviral technologies may&#13;<br \/>\nonly be incorporated into products that are or will be registered with the US&#13;<br \/>\nEPA.\u00a0<\/em><a href=\"https:\/\/www.microban.com\/contact\"><em>Contact your Microban representative for further&#13;<br \/>\ninformation<\/em><\/a><em>.<\/em><\/p>\n<\/p><\/div>\n\n<br \/><a href=\"https:\/\/www.media-outreach.com\/news\/2021-11-09\/103763\/microban-international-announces-a-new-range-of-antiviral-technologies\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NORTH CAROLINA, USA&#13; &#8211; News Direct &#8211; 9 November 2021 &#8211;\u00a0Microban International, the global leader in&#13; antimicrobial solutions, odour control and residual sanitisation\/disinfection&#13; solutions, is pleased to announce a new range of antiviral technologies that are&#13; proven to reduce viral loading on products and surfaces. Microban has long been&#13; a trusted partner in a wide &hellip;<\/p>\n","protected":false},"author":1,"featured_media":18698,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[60],"tags":[],"_links":{"self":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/18697"}],"collection":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/comments?post=18697"}],"version-history":[{"count":0,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/posts\/18697\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media\/18698"}],"wp:attachment":[{"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/media?parent=18697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/categories?post=18697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eodishasamachar.com\/en\/wp-json\/wp\/v2\/tags?post=18697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}